Director dealings: Astrazeneca CEO raises stake

18th Sep 2026 14:14

(Sharecast News) - Astrazeneca revealed on Friday that chief executive Pascal Soriot had acquired 60,000 ordinary shares in the FTSE 100-listed drugmaker.

Soriot, who took over as CEO in October 2012, purchased the shares at an average price of 12,102p each, for a total value of £7.26m.

As of 1540 BST, Astrazeneca shares were up 0.82% at 12,530p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Astrazeneca (AZN)

Director name: Soriot,Pascal

Amount purchased: 60,000 @ 12,102.00p

Value: £7,261,199.80

Trustpilot Group (TRST)

Director name: Roy ,Marcus

Amount purchased: 45,436 @ 218.98p

Value: £99,493.93

Trustpilot Group (TRST)

Director name: Byng-Thorne,Zillah

Amount purchased: 27,746 @ 215.14p

Value: £59,692.75

Trustpilot Group (TRST)

Director name: Byng-Thorne,Zillah

Amount purchased: 17,854 @ 222.87p

Value: £39,791.21

Tmt Investments (TMT)

Director name: Selegenev,Alexander

Amount purchased: 10,000 @ $3.23

Value: $32,300.00

Tmt Investments (TMT)

Director name: Selegenev,Alexander

Amount purchased: 3,000 @ $3.46

Value: $10,380.00

Domino's Pizza Group (DOM)

Director name: Perriss,Robyn

Amount purchased: 4,850 @ 204.50p

Value: £9,918.40

Top Director Sells